Abstract
Ischemic stroke (IS) and Chagas disease are strongly related. Nevertheless, little attention has been paid to this association and its natural history. The current guidelines concerning the management and secondary prevention of IS are largely based on the incomplete information or extrapolation of knowledge from other stroke etiologies. We performed a retrospective study which compared stroke etiologies among a cohort of hospitalized patients with IS and Chagas disease. The Instituto de Pesquisa Evandro Chagas/Fundação Oswaldo Cruz (IPEC/FIOCRUZ) embolic score was also used to identify and evaluate the risk of embolism in this population. A total of 86 patients were included in the analysis. The mean age of the study population was 58 years, and 60 % were men. According to the Trial of Org 10172 in Acute Stroke Treatment (TOAST) Classification, 45 % of the strokes were of undetermined etiology and 45 % of cardioembolic origin, while the Stop Stroke Study/Causative Classification System (SSS/CCS) TOAST indicated that 34 % were undetermined and 50 % cardioembolic (p < 0.01); 44 % of these patients were classified as having a high embolic risk according to the IPEC/FIOCRUZ score. Among the undetermined causes, 83.3 % fulfilled the criteria for embolic stroke of undetermined source (ESUS). The SSS/CCS TOAST etiological classification system was superior to the classical TOAST criteria in identifying a cardioembolic etiology in patients with ischemic stroke and Chagas disease. The IPEC/FIOCRUZ score did not correlate with the number of patients who were determined to have cardioembolic stroke etiologies. The current guidelines for stroke prevention should be reviewed in this population.
Similar content being viewed by others
References
World Health Organization (2005) Making health research work for poor people. Seventeenth programme report UNDP/TDR17:30–34
Carod-Artal FJ (2013) Policy implications of the changing epidemiology of Chagas disease and stroke. Stroke 44:2356–2360
Carod-Artal FJ, Gascon J (2010) Chagas disease and stroke. Lancet Neurol 9:533–542
Chagas C (1909) Nova tripanozomiase humana: estudos sob a morfologia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., s. SP Agente etiológico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz 1:159–218
Mandell GL, Bennet JE, Dolin R (2010) Principles and practice of infectious disease, Chap 277, 7th edn. Elsevier, USA, pp 3481–3487
Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG (2005) Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke 36:965–970
Cardoso EN, Macedo FYB, Garcia MN, Garcia DC, Benjo AM, Aguilar D, Jneid H, Bozkurt B (2014) Chagas cardiomyopathy is associates with higher incidence of stroke: a meta-analysis of observational studies. J Card Fail 20(12):931–938
Sousa AS, Xavier SS, de Freitas GR, Hasslocher-Moreno A (2008) Prevention strategies of cardioembolic ischemic stroke in Chagas disease. Arq Bras Cardiol 91:280–284
Andrade JP, Neto JAM, Paola AAV, Vilas-Boas F, Oliveira GMM, Bacal F, Almeida DR, Bocchi EA, Filho AAF, Moreira MCV, Xavier SS, Junior WAO, Dias JCP (2011) I Latin American Guidelines for the diagnosis and treatment of chagas’ heart disease: executive summary. Arq Bras Cardiol 96(6):434–442
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh E (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24(1):35–41
Ay H, Furie KL, Singhaal A, Smith W, Sorensen AG, Kortoshetz WJ (2007) An evidence-based causative classification system for acute ischemic stroke. Ann Neurol 58:688–697
Ay H (2005) Causative classification system for ischemic stroke. https://ccs.mgh.harvard.edu/ccs_title.php. Accessed from 15 January to 10 May 2016
Ay H, Benner T, Arsava EM, Furie K, Singhaal A, Jensen MB, Towfighi A, Smith E, Chong JY, Koroshetz WJ, Sorensen GA (2007) A computerized algorithm for etiologic classification of ischemic stroke: the causative classification of stroke system. Stroke 38:2979–2984
Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnel MJ, Sacco RL, Connoly SJ (2014) Embolic stroke of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429–438
Carod-Artal FJ, Vargas AP, Melo M, Horan TA (2003) American trypanosomiasis (Chagas’ disease): an unrecognised cause of stroke. J Neurol Neurosurg Psychiatry 74:516–518
Pitella JE (1984) Ischemic cerebral changes in the chronic chagasic cardiopathy. Arq Neuropsiquiatr 42:105–115
Oliveira-Filho J, Viana LC, Vieira de Melo RM, Faiçal F, Torreão JA, Villar FA, Reis FJ (2005) Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas disease cohort. Stroke 36:2015–2017
Paixão LC, Ribeiro AL, Valaccio RA, Teixeira AL (2009) Chagas Disease: independent risk factor for stroke. Stroke 40(12):3691–3694
Carod-Artal FJ, Vargas AP, Falcão T (2011) Stroke in asymptomatic Trypanosoma cruzi-infected patients. Cerebrovasc Dis 31:24–28
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J (2014) CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370(26):2478–2486
Dias JP (2006) Doença de Chagas: sucessos e desafios. Cad Saude Publica 10:2020–2021
Acknowledgments
The authors would like to thank the SARAH network of rehabilitation hospitals for providing the means and time for the realization of this research paper. No financial benefits were acquired by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical standards
The study protocol was approved by the ethics committee of SARAH hospital.
Conflicts of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Montanaro, V.V.A., da Silva, C.M., de Viana Santos, C.V. et al. Ischemic stroke classification and risk of embolism in patients with Chagas disease. J Neurol 263, 2411–2415 (2016). https://doi.org/10.1007/s00415-016-8275-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-016-8275-0